학술논문
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial
Document Type
Article
Author
Source
In: Graefe's Archive for Clinical and Experimental Ophthalmology . (Graefe's Archive for Clinical and Experimental Ophthalmology, 2024)
Subject
Language
English
ISSN
1435702X
0721832X
0721832X